BPX2, BPF BPF. In a later investigation Weigert, Calcutt and Powell showed that after application of 3:4-benzypyrene to the skin of mice only the presence of BPX2 was detected.
That a similarity exists between the metabolism of 3:4-benzpyrene in animals and human beings (patients suffering from leukaemia) has already been shown (Iversen, 1947) .
The following investigation shows that the intravenous injection of 3:4-benzpyrene in human beings has an effect upon the amount of nitrogen in plasma, and that only-or mainly-the BPX1 derivatives are found in plasma.
MATERIAL AND METHODS.
One part of 3:4-benzpyrene was fused with four parts of Postonal (a polymerization product of ethylenoxide), and carbon-dioxide free distilled water was added to the me]ted mixture, which was then shaken vigorously. This emulsion was stable for 3-4 hours. The diameter of the particles of the emulsion was between 6 to 15k.
Immediately after the emulsion was prepared it was injected intravenously in patients suffering from myeloid or lymphatic leukaemia. The doses used were 300, 500 and 800 mg. 3:4-benzpyrene in 30, 40 and 80 c.c In order to make sure that the emulsifier (Postonal) itself had no effect on the amount of nitrogen in plasma, 8 g. of Postonal, which is more than twice the amount ordinarily used for the benzpyrene emulsions, were injected intravenously into a patient. No changes in the plasma as described above were noticed. to be 0.8599. The same quotient for the X1 derivative is unknown and could not be determined, as it was not possible to obtain the X1 derivative in a pure form, but the quotient must be higher than 1 00, as the absorption of the Xl derivative is more intense at 380 m,. than at 385 m,.
The quotients obtained from alcohol-extracted plasma at different times before and after the injection are shown in Fig. 1 , curves G and H. The curves show that the concentration of unchanged benzpyrene rapidly decreases, whereas the concentration of changed benzpyrene (X1 derivative) rapidly increases. The curves further show that the time at which the rate of conversion is highest nearly coincides with the time at which the decrease in nitrogen-(protein-) content of the plasma is most conspicuous. Additionally the curves indicate that after the maximum concentration of changed hydrocarbon has been reached, elimination takes place at a constant speed.
That the conversion may take place in the liver after an intravenous injection is an obvious consideration, and the following experiment would indicate that this is the case in rabbits:
Blood is transfused through a living rabbit liver (Nielsen, 1933) , and to the circulating blood is added 10 mg. 3:4-benzpyrene emulsified in the usual way; samples of blood are taken before and at various times after the injection. Fig. 3 shows, as in the case of human beings, that the absorption maxima of 3:4-benzpyrene are altered gradually to the maxima of absorption characteristic of the X1 derivatives. That these curves appear higher and higher on the ordinate axis may be accounted for by the fact that it is not possible for the system to excrete. The variations in the quotient 380/385 m,u. from two such experiments with rabbits are seen in Fig. 4 , curves D and E. The quotients for the alcohol extracted livers were 1.10 and 1.02. The fact that these quotients are higher than in the sera strongly supports the theory that the conversion of the hydrocarbon takes place in the liver. Fig. 4 , curve c, shows the variations of the quotient 380/385 mir. for alcoholextracted plasma from a patient suffering from lymphatic leukaemia. This curve has a noticeably different course from the quotient curve obtained from myeloid leukaemia, which may mean a slower rate of conversion, in the case of lymphatic leukaemia. WVhether this difference in the rate of conversion of 3:4-benzpyrene is due to differences in the individuals themselves, to differences in the amount of benzpyrene injected, or to a difference between myeloid and lymphatic leukaemia, it is not yet possible to decide, since the material'on lymphatic leukaemia has been too limited to permit definite conclusions. Fig. 4 perhaps to be mentioned in this connection that the patients during, or immediately after, but never later than half an hour after the injection, sometimes got slight attacks of pulmonary infarcts.
Whether one considers the changes in the amount of nitrogen (protein) in plasma as attached to the metabolism of 3:4-benzpyrene or as bearing no relation Mlurt$. to the conversion of 3:4-benzpyrene, but accompanying the intravenous injection of 3:4-benzpyrene in an apparently regular way, it is possible, if one considers the concentration of unchanged benzpyrene as being highest in the blood sample obtained immediately after the injection, to calculate the relative amounts of X1 derivative of the different blood samples by using the following equation: In relation to an intravenous injection of 3:4-benzpyrene a decrease in the amount of nitrogen (protein) in plasma is observed. The decrease is of rather short duration, and is most conspicuous at the time when the conversion of 3:4-benzpyrene is most intense.
After intravenous injection of 3:4-benzpyrene in human beings only the absorption characteristic of the BPX1 derivatives are observed. Experiments with rabbits indicate the probability that the conversion of 3:4-benzpyrene after intravenous injection takes place in the liver.
A method is given of estimating the process of conversion. Relative estimations of the amounts of X1 derivative in plasma show that both the conversion of 3:4-benzpyrene to the X1 derivative and the elimination of X1 derivative from plasma follow the equation for the rate of a monomolecular reaction.
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